R. Douglas Norby, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 45,442 shares at $188.24 ($8.5M) on 2015-12-11, disclosed to the SEC on 2015-12-15.
Open-market sale of $8.5M ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $186.97 | 34 | $6K | 0.1% |
| 2 | $187.57 | 35,575 | $6.7M | 78.2% |
| 3 | $188.24 | 9,833 | $1.9M | 21.7% |
| Total | $187.71 avg | 45,442 | $8.5M | 100% |
| Filing → |
| ALXN | SELL | 2012-12-12 | $2.0M | — | Filing → |
| ALXN | SELL | 2012-03-12 | $2.6M | — | Filing → |
| ALXN | SELL | 2011-10-31 | $3.1M | — | Filing → |